November 2, 2023
Mad Hedge Biotech and Healthcare Letter November 2, 2023 Fiat Lux Featured Trade: (SLICING THROUGH DOUBT) (CRSP), (VRTX), (BLUE), (BEAM), (AMGN), (REGN)
This author has not written his bio yet.
But we are proud to say that april@madhedgefundtrader.com contributed 2784 entries already.
Mad Hedge Biotech and Healthcare Letter November 2, 2023 Fiat Lux Featured Trade: (SLICING THROUGH DOUBT) (CRSP), (VRTX), (BLUE), (BEAM), (AMGN), (REGN)
In the intricate world of medical breakthroughs, September 14, 1990, stands out like a sore thumb—or perhaps, a healing one. On this day, the baseball world was left agog as Ken Griffey Jr. and Sr. knocked out back-to-back home runs, a feat as rare as hen’s teeth. Meanwhile, in a quieter corner of the planet,
Global Market Comments November 2, 2023 Fiat Lux Featured Trade: (THE SECOND AMERICAN INDUSTRIAL REVOLUTION), (INDU), (SPY), (QQQ), (GLD), (DBA), (TSLA), (GOOGL), (XLK), (IBB), (XLE) (TESTIMONIAL)
(THIS AI STOCK IS GAINING ATTENTION) November 1, 2023 Hello everyone, Welcome to November. Wall Street is upbeat about an AI stock called Arista. On Monday, the company earnings exceeded Wall Street expectations on both the top and bottom lines. Earnings: $1.83/share Revenue: $1.51 Analysts forecast: Earnings: $1.58/share Revenue: $1.48 billion Arista also
Mad Hedge Biotech and Healthcare Letter October 31, 2023 Fiat Lux Featured Trade: (A SEA OF POSSIBILITIES) (PFE), (MRNA), (NVAX)
In the cutthroat world of pharmaceuticals, Pfizer (PFE) seems to be having a bit of a moment. And not the kind you'd want to experience yourself. With shares flirting dangerously close to their 52-week low, investors are left scratching their heads. Is this a rare stock market sale, or is Pfizer showing us warning signs?
Global Market Comments October 31, 2023 Fiat Lux ANOTHER SPECIAL SOLAR ISSUE Featured Trade: (HOW TO BUY A SOLAR SYSTEM), (SCTY), (SPWR), (TSLA), (USO)
Mad Hedge Technology Letter October 30, 2023 Fiat Lux Featured Trade: (WHY MEGACAP TECH IS THE ONLY SHOW IN TOWN) (BIG TECH), (ETF), (COMPQ)
Megacap stocks continue to make hay when the sun shines in 2023. The question is, why? After all, many other great companies have arguably much better valuations, fundamentals, and affordable PE ratios. Big tech stocks are expensive, yet buyers keep maneuvering to bid up the stock. What gives? The surge in the most hated sectors
“Any new technology tends to go through a 25-year adoption cycle.” – Said Venture Capitalist Marc Andreessen
Legal Disclaimer
There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.